BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27336915)

  • 1. Cystic Fibrosis Lung Immunity: The Role of the Macrophage.
    Bruscia EM; Bonfield TL
    J Innate Immun; 2016; 8(6):550-563. PubMed ID: 27336915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Innate and Adaptive Immunity in Cystic Fibrosis.
    Bruscia EM; Bonfield TL
    Clin Chest Med; 2022 Dec; 43(4):603-615. PubMed ID: 36344069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.
    Meyer M; Huaux F; Gavilanes X; van den Brûle S; Lebecque P; Lo Re S; Lison D; Scholte B; Wallemacq P; Leal T
    Am J Respir Cell Mol Biol; 2009 Nov; 41(5):590-602. PubMed ID: 19244203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.
    Bodas M; Mazur S; Min T; Vij N
    Respir Res; 2018 Jan; 19(1):2. PubMed ID: 29301535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts of immune dysregulation in cystic fibrosis.
    Rieber N; Hector A; Carevic M; Hartl D
    Int J Biochem Cell Biol; 2014 Jul; 52():108-12. PubMed ID: 24495876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis and the innate immune system: therapeutic implications.
    Conese M
    Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):8-22. PubMed ID: 21348822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations.
    Lara-Reyna S; Holbrook J; Jarosz-Griffiths HH; Peckham D; McDermott MF
    Cell Mol Life Sci; 2020 Nov; 77(22):4485-4503. PubMed ID: 32367193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.
    Tarique AA; Sly PD; Holt PG; Bosco A; Ware RS; Logan J; Bell SC; Wainwright CE; Fantino E
    J Cyst Fibros; 2017 Jul; 16(4):475-482. PubMed ID: 28428011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung disease modifier genes in cystic fibrosis.
    Guillot L; Beucher J; Tabary O; Le Rouzic P; Clement A; Corvol H
    Int J Biochem Cell Biol; 2014 Jul; 52():83-93. PubMed ID: 24569122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early pulmonary inflammation and lung damage in children with cystic fibrosis.
    Schultz A; Stick S
    Respirology; 2015 May; 20(4):569-78. PubMed ID: 25823858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
    Magalhães M; Rivals I; Claustres M; Varilh J; Thomasset M; Bergougnoux A; Mely L; Leroy S; Corvol H; Guillot L; Murris M; Beyne E; Caimmi D; Vachier I; Chiron R; De Sario A
    Clin Epigenetics; 2017; 9():19. PubMed ID: 28289476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease modifying genes in cystic fibrosis.
    Slieker MG; Sanders EA; Rijkers GT; Ruven HJ; van der Ent CK
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():7-13. PubMed ID: 15996905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammation and cystic fibrosis].
    Delacourt C
    Arch Pediatr; 2003 Sep; 10 Suppl 2():338s-341s. PubMed ID: 14671931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.
    Lubamba BA; Jones LC; O'Neal WK; Boucher RC; Ribeiro CM
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1449-61. PubMed ID: 26331676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The innate immune system in cystic fibrosis lung disease.
    Bals R; Weiner DJ; Wilson JM
    J Clin Invest; 1999 Feb; 103(3):303-7. PubMed ID: 9927489
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune responses in cystic fibrosis: are they intrinsically defective?
    Ratner D; Mueller C
    Am J Respir Cell Mol Biol; 2012 Jun; 46(6):715-22. PubMed ID: 22403802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Immunity in Cystic Fibrosis.
    Bojanowski CM; Lu S; Kolls JK
    J Immunol; 2021 Dec; 207(12):2901-2912. PubMed ID: 35802761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.
    Jaganathan D; Bruscia EM; Kopp BT
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense.
    Svedin E; Utorova R; Hühn MH; Larsson PG; Stone VM; Garimella M; Lind K; Hägglöf T; Pincikova T; Laitinen OH; McInerney GM; Scholte B; Hjelte L; Karlsson MCI; Flodström-Tullberg M
    J Infect Dis; 2017 Dec; 216(10):1308-1317. PubMed ID: 28968805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator.
    Zhang PX; Murray TS; Villella VR; Ferrari E; Esposito S; D'Souza A; Raia V; Maiuri L; Krause DS; Egan ME; Bruscia EM
    J Immunol; 2013 May; 190(10):5196-206. PubMed ID: 23606537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.